Table 1.
Inclusion criteria | Exclusion criteria |
KTRs
|
|
Healthy controls
|
|
*That is, significant comorbidity including unstable hypertension, potentially lethal arrhythmia, myocardial infarction within 6 months, unstable angina, active liver disease, uncontrolled diabetes mellitus (HbA1c ≥9%), advanced cerebral or peripheral vascular disease which, in the opinion of the patient’s own clinician, may either put the patient at risk because of participation in the study, or may influence the result of the study, or the patient’s ability to participate in the study.
BMI, body mass index; CMR, cardiac MRI; KTR, kidney transplant recipient.